Avai Bio (AVAI) Price to Earnings (2020 - 2026)

Avai Bio has disclosed Price to Earnings across 7 years of filings, most recently posting 36.25 for Q2 2026.

• In Q2 2026, Price to Earnings rose 78.22% year-over-year to 36.25; the TTM figure through Jun 2026 stood at 11.03 (up 70.63% YoY), while the FY2026 annual figure was 28.02, up 51.46% from the prior year.
• Price to Earnings came in at 36.25 for Q2 2026 at Avai Bio, up from 192.13 in the prior quarter.
• In the past five years, Price to Earnings ranged from a high of 4313.51 in Q1 2022 to a low of 222.58 in Q2 2023.
• Average Price to Earnings over 5 years is 285.84, with a median of 46.14 recorded in 2023.
• Year-over-year, Price to Earnings jumped 625.98% in 2022 and tumbled 700.85% in 2026.
• Over 5 years, Price to Earnings stood at 369.24 in 2022, then tumbled by 115.18% to 56.03 in 2023, then jumped by 381.36% to 157.66 in 2024, then tumbled by 160.08% to 94.73 in 2025, then jumped by 61.74% to 36.25 in 2026.
• Per Business Quant data, the three most recent Price to Earnings figures were 36.25 in Q2 2026, 192.13 in Q1 2026, and 94.73 in Q4 2025.